4-hydroxycyclophosphamide has been researched along with Alopecia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farjo, B; Farjo, N; Haslam, IS; Paus, R; Smart, E | 1 |
| Beijnen, JH; Dalesio, O; de Jonge, ME; Huitema, AD; Mathôt, RA; Rodenhuis, S | 1 |
2 other study(ies) available for 4-hydroxycyclophosphamide and Alopecia
| Article | Year |
|---|---|
Inhibition of ATP binding cassette transporter B1 sensitizes human hair follicles to chemotherapy-induced damage.
Topics: Alopecia; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Cell Culture Techniques; Cyclophosphamide; Doxorubicin; Hair Follicle; Humans; Scalp; Verapamil | 2019 |
Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy.
Topics: Adolescent; Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Cyclophosphamide; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms; Thiotepa; Triethylenephosphoramide | 2002 |